Hrt Financial LP Silk Road Medical Inc Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$6.29 - $15.72 $89,827 - $224,497	14,281 Added 64.26%	36,504 $447,000
Q3 2023 Nov 13, 2023	BUY	$14.99 - $32.65 $333,122 - $725,580	22,223 New	22,223 $333,000
Q1 2023 May 12, 2023	BUY	$38.09 - $57.79 $488,580 - $741,272	12,827 New	12,827 $501,000
Q4 2021 Feb 14, 2022	SELL	$39.32 - $61.61 $944,191 - $1.48 Million	-24,013 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$44.0 - $65.8 $1.06 Million - $1.58 Million	24,013 New	24,013 $1.32 Million
Q1 2021 May 17, 2021	SELL	$46.31 - $62.7 $217,101 - $293,937	-4,688 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$55.51 - $69.94 $260,230 - $327,878	4,688 New	4,688 $295,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.